Preventing peritoneal fibrosis--an ace up our sleeve?
Witowski
Janusz
J
Department of Pathophysiology, University Medical School, Poznań, Poland.
Jörres
Achim
A
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D005355:Fibrosis / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010537:Peritoneum / Q000473:pathology* / Q000503:physiopathology; D011945:Receptors, Angiotensin / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin